Darifenacin Hydrobromide extended Release IP 7.5
Nov 02, 2022
Derifenac 7.5
Darifenacin Hydrobromide extended Release IP 7.5 is used to treat an overactive bladder. By relaxing the muscles in the bladder, Darifenacin Hydrobromide extended Release IP 7.5 improves your ability to control your urination. Darifenacin Hydrobromide extended Release IP 7.5 helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
For more information please contact:
Recent Post
The Science of BUDESHINE: How Budesonide Aqueous Spray Works for You
Best Anti-Dandruff Shampoo with Luliconazole, Salicylic Acid & Zinc Pyrithione in 2026
Managing Diabetic Neuropathy: Why Pregabalin, Methylcobalamin & Duloxetine is the Best Trio
Powerful Triple Action Cough Syrup: Terbutaline + Ambroxol + Guaiphenesin for Better Breathing
Dapagliflozin 10mg Glimepiride 2mg Metformin 500mg ER Tablets: Best Triple Therapy for Type 2 Diabetes in 2026
Trazodone 25 mg for Sleep: Low Dose Uses, Proper Dosage & Side Effects Explained
How L-Tyrosine Multivitamin Tablets Boost Brain Focus, Energy & Stress Relief
How Sitagliptin, Metformin SR, and Pioglitazone Work Together (Mechanism)
Light Moisturising Cream for Face – EUROSOFT MOIST CREAM
Trazodone Hydrochloride 100 mg and 50 mg Tablets for Depression
